CODEXIS, INC. (CDXS)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 15,328 | 7,543 | 12,833 | 7,979 |
| Selling, general and administrative | 12,317 | 12,355 | 13,568 | 15,671 |
| Research and development | 13,775 | 12,942 | 11,505 | 11,413 |
| Cost of product revenue | 2,098 | 2,732 | 4,317 | 3,462 |
| Asset impairment and other charges | - | - | - | 165 |
| Total costs and operating expenses | 28,190 | 28,029 | 29,390 | 30,711 |
| Loss from operations | -12,862 | -20,486 | -16,557 | -22,732 |
| Interest income | 584 | 751 | 849 | 972 |
| Interest and other expense, net | -984 | -942 | -4,922 | -985 |
| Loss before income taxes | -13,262 | -20,677 | -20,630 | -22,745 |
| Provision for income taxes | 10 | 11 | 10 | 10 |
| Net loss | -13,272 | -20,688 | -20,640 | -22,755 |
| Net loss per share, basic (in dollars per share) | -0.16 | -0.25 | -0.29 | -0.32 |
| Net loss per share, diluted (in dollars per share) | -0.16 | -0.25 | -0.29 | -0.32 |
| Weighted average common stock shares used in computing net loss per share, basic (in shares) | 85,389,000 | 82,410,000 | 72,032,000 | 70,376,000 |
| Weighted average common stock shares used in computing net loss per share, diluted (in shares) | 85,389,000 | 82,410,000 | 72,032,000 | 70,376,000 |